NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
11/25/2025
Back to search
Official data from USPTO
TREELINE BIOSCIENCES
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TREELINE BIOSCIENCES
ST13
US500000090981524Class
5, 42
Filing
90981524
Registration
8042862
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
59
Latest update
11/26/2025
Trademark type
Word
Nice classes
5, 42
Filing date
04/22/2021
Registration date
11/25/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
11/25/2025
Last transaction
11/26/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Intent to use
First use anywhere
12/27/2024
First use in commerce
12/27/2024
Drawing code
4
Owner type
03
Owner location
Watertown, MA
Examiner
NGUYEN,NICOLE ASHLEY
Law office
M50
Current location
PUBLICATION AND ISSUE SECTION
Holders and representatives
Holders
Treeline Biosciences, Inc.
Treeline Biosciences, Inc.
Representatives
Caitlin R. Byczko Barnes & Thornburg LLP
Technical classification
Nice Classes
Class 5Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
pharmaceutical productspreparations for the prevention and treatment of cancerlymphomas
Class 42
pharmaceutical research and development in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; medicalpharmaceuticalscientific research in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; medicalpharmaceuticalscientific research in the field of biomarkers for use in diagnosingpreventingtreating diseases and disordersnamely cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; clinical research and testing services not for medical diagnostic purposes in the field of cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders; providing medical and scientific research information in the field of pharmaceuticals and clinical trials for use in diagnosingpreventingtreating diseases and disordersnamely cancercarcinomassarcomasmyelomaslymphomasautoimmune diseases and disordersimmunologic-based diseases and disordersinflammatory diseases and disordersimmune diseases and disorders
Publications
History of USPTO decisions and trademark events.
59 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
11/25/2025
SUNA
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
11/06/2025
CNPR
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
11/06/2025
SUPC
STATEMENT OF USE PROCESSING COMPLETE
10/31/2025
DPCC
DIVISIONAL PROCESSING COMPLETE
10/31/2025
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
10/30/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/21/2025
EX4G
SOU EXTENSION 4 GRANTED
05/20/2025
IUAF
USE AMENDMENT FILED
05/16/2025
EEXT
SOU TEAS EXTENSION RECEIVED
05/16/2025
EXT4
SOU EXTENSION 4 FILED
05/15/2025
DRRR
DIVISIONAL REQUEST RECEIVED
01/17/2025
ERTD
TEAS REQUEST TO DIVIDE RECEIVED
01/17/2025
EISU
TEAS STATEMENT OF USE RECEIVED
01/17/2025
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
01/14/2025
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
01/14/2025
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
01/14/2025
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
12/11/2024
EX3G
SOU EXTENSION 3 GRANTED
12/11/2024
AITU
CASE ASSIGNED TO INTENT TO USE PARALEGAL
12/09/2024
EXT3
SOU EXTENSION 3 FILED
11/12/2024
EEXT
SOU TEAS EXTENSION RECEIVED
11/12/2024
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
06/17/2024
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
06/17/2024
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
06/17/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
05/07/2024
EX2G
SOU EXTENSION 2 GRANTED
05/06/2024
EXT2
SOU EXTENSION 2 FILED
05/06/2024
EEXT
SOU TEAS EXTENSION RECEIVED
05/06/2024
DOCK
ASSIGNED TO EXAMINER
01/12/2024
EXRA
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
10/05/2023
EX1G
SOU EXTENSION 1 GRANTED
10/03/2023
EXT1
SOU EXTENSION 1 FILED
10/03/2023
EEXT
SOU TEAS EXTENSION RECEIVED
10/03/2023
NOAM
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
05/16/2023
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/21/2023
PUBO
PUBLISHED FOR OPPOSITION
03/21/2023
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
03/01/2023
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
02/13/2023
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
02/08/2023
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
02/08/2023
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
02/08/2023
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
08/10/2022
GNFR
FINAL REFUSAL E-MAILED
08/10/2022
CNFR
FINAL REFUSAL WRITTEN
08/10/2022
DOCK
ASSIGNED TO EXAMINER
07/14/2022
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
06/22/2022
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
06/21/2022
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
06/21/2022
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
12/22/2021
GNRT
NON-FINAL ACTION E-MAILED
12/22/2021
CNRT
NON-FINAL ACTION WRITTEN
12/22/2021
DOCK
ASSIGNED TO EXAMINER
12/16/2021
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/20/2021
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/20/2021
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/20/2021
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
07/29/2021
NWAP
NEW APPLICATION ENTERED
04/26/2021
Continuous trademark protection
Get notified about every new filing that threatens TREELINE BIOSCIENCES or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.